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Abstract
Background: Subjective health status is the result of an interaction between physiological and
psychosocial factors in patients with chronic obstructive pulmonary disease (COPD). However,
there is little understanding of multivariate explanations of subjective health status in COPD. The
purpose of this study was to explore what determines subjective health status in COPD by
evaluating the relationships between background variables such as age and sex, predicted FEV1%,
oxygen saturation, breathlessness, anxiety and depression, exercise capacity, and physical and
mental health.
Methods: This study had a cross-sectional design, and included 100 COPD patients (51% men,
mean age 66.1 years). Lung function was assessed by predicted FEV1%, oxygen saturation by
transcutaneous pulse oximeter, symptoms with the St George Respiratory Questionnaire and the
Hospital Anxiety and Depression Scale, physical function with the Incremental Shuttle Walking
Test, and subjective health status with the SF-36 health survey. Linear regression analysis was used.
Results: Older patients reported less breathlessness and women reported more anxiety (p <
0.050). Women, older patients, those with lower predicted FEV1%, and those with greater
depression had lower physical function (p < 0.050). Patients with higher predicted FEV1%, those
with more breathlessness, and those with more anxiety or depression reported lower subjective
health status (p < 0.050). Symptoms explained the greatest variance in subjective health status
(35%–51%).
Conclusion: Symptoms are more important for the subjective health status of patients with
COPD than demographics, physiological variables, or physical function. These findings should be
considered in the treatment and care of these patients.
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Chronic obstructive pulmonary disease (COPD) is a pro-
gressive lung disease characterized by impairment of lung
function with airway obstruction, which is most fre-
quently the result of tobacco smoke [1]. COPD is one of
the major causes of morbidity and mortality worldwide.
Many people suffer from this disease for years and die
from it or its complications [1]. Hoogendoorn et al. [2]
estimated that the prevalence of diagnosed COPD, the
number of deaths, and the associated health costs will
increase during the next decade. In addition to the social
strain, COPD also influences the patients' symptoms,
function, and subjective health status [3].
An important issue in understanding the complexity of
COPD as an illness and thereby its management, is what
determines the subjective health status of these patients.
Wilson and Cleary [4] suggested a model that clarified the
relationships between biological and physiological varia-
bles, symptoms, function, general health perception, and
overall quality of life, and the impact of the characteristics
on individuals and their environments. This model indi-
cated that biological and physiological processes affect the
perception of symptoms, which in turn affects function,
general health perception, and overall quality of life.
However, these authors point out that this main causal
direction in their model does not imply that there are not
reciprocal relationships [4].
Several studies of COPD patients have examined different
associations between physiological variables, symptoms,
physical function, and subjective health status. For exam-
ple, de Torres et al. [5] investigated differences in physio-
logical factors and sex, and reported that women have
better oxygen saturation than men [5]. In terms of symp-
toms, studies of COPD patients have shown that higher
oxygen consumption is associated with improved mood,
and lower predicted FEV1% is associated with more
breathlessness [6,7]. Furthermore Cleland et al [8] found
that older COPD patients report less anxiety and depres-
sion than younger. Anderson [6] found that greater
depression is associated with lower physical function.
With regard to subjective health status, studies have
reported that women suffering from COPD and older
COPD patients report worse physical health [5,9,10].
Other studies have reported that lower predicted FEV1%
and functional exercise capacity and greater anxiety and
depression are associated with lower subjective health sta-
tus [8,11-13].
The abovementioned studies mainly investigated bivari-
ate relationships between demographics, physiological
variables, symptoms, physical function, and subjective
health status, but lack a multivariate perspective on sub-
jective health status in COPD. According to the biopsy-
chosocial perspective, subjective health status cannot be
explained by biological and physiological factors alone.
Instead, subjective health status is the result of an interac-
tion between physiological and psychosocial factors [14].
COPD is a chronic disease, which must be managed rather
than cured. Therefore, knowledge about what determines
subjective health status in this group of patients is relevant
for the treatment of COPD, and for the care and rehabili-
tation of patients. To this end, the aim of the present study
was to explore the determinants of subjective health status
in COPD by evaluating the relationships between back-
ground variables such as age and sex, predicted FEV1%,
oxygen saturation, breathlessness, anxiety and depression,
exercise capacity, and physical and mental health. Based
on previous studies in COPD patients and the conceptual
model of Wilson and Cleary, the following conceptual
model is postulated (Figure 1).
A proposed model for the relationships between demographics, physiological variables, symptoms, physical function and sub-jective health statusFigure 1
A proposed model for the relationships between demographics, physiological variables, symptoms, physical 
function and subjective health status.Page 2 of 8
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Design, sample, and data collection
This study had a cross-sectional design, and included 136
patients with COPD recruited from the outpatient clinic at
a medium-sized hospital between August 2005 and
August 2007. The patients were referred to the out-patient
clinic to attend a rehabilitation programme designed for
COPD patients. Those who fulfilled the criteria listed
below were invited to participate in this study.
Inclusion criteria for the study
• Age > 35 years
• Diagnosed with COPD by a respiratory physician
• Symptoms such as breathlessness, chronic cough, and
sputum production
• FEV1/FVC < 70% and FEV1 < 80% predicted
• Able to read and write Norwegian
Exclusion criteria for the study
• Using long-term oxygen treatment
• Unstable heart disease
Patients were given verbal and written information about
the study, an informed consent form giving their permis-
sion to take part in the study, and a questionnaire with a
hand-signed cover letter and a pre-stamped envelope
when they underwent the examination at the out-patient
clinic. Each patient's respiratory symptoms and physical
health were assessed by a physician, nurse, and physio-
therapist, all specialized in pulmonary disease. All
patients underwent height and weight measurements,
spirometry, an Incremental Shuttle Walking Test (ISWT),
and electrocardiogram. Those who had not returned the
questionnaire within two weeks were sent a reminder.
This study was performed according to the Declaration of
Helsinki and was approved by the hospital unit, the
Regional Committee for Medical Research Ethics, and the
Norwegian Social Science Data Services.
Measures
The measurements described below were used to examine
demographics, physiological variables, symptoms, physi-
cal function, and subjective health status.
(A) Demographics
The patients completed a questionnaire consisting of the
following variables: age (continuous variable, in years)
and sex.
(B) Physiological variables
Data on lung function and transcutaneous oxygen satura-
tion were collected during the visit at the out-patient clinic.
Pulmonary function tests
Spirometry was performed with a Vitalograph Alpha
spirometer, according to international guidelines [15].
Forced expiratory volume in one second (FEV1) and
forced vital capacity (FVC) were measured and the pre-
dicted values calculated according to a Norwegian refer-
ence population [16]. FEV1/FVC% was calculated and a
value < 0.7 together with FEV1 < 80% predicted was used
as a diagnostic criterion for COPD. FEV1(litre) and FEV1 as
a percentage of the predicted value (predicted FEV1%)
were used as a measure of lung function.
Oxygen saturation
Transcutaneous oxygen saturation (SaO2%) was meas-
ured with a Konica Minolta PulsOx-3i Pulse Oximeter.
SaO2% was measured immediately before the incremen-
tal shuttle walking test [17].
(C) Symptoms
To measure their symptoms, the patients filled out a ques-
tionnaire on breathlessness, anxiety, and depression.
Breathlessness
Breathlessness was measured with the St George's Respira-
tory Questionnaire (SGRQ) [18]. The SGRQ is a disease-
specific instrument for patients suffering from pulmonary
disease. The questionnaire consists of 76 items divided
into three components: 1) symptoms, 2) activity, and 3)
impact. A sum is calculated for each component. Each of
the scores ranges from 0 to 100, the lower scores indicat-
ing better health status [19-21]. The SGRQ has been trans-
lated into different languages and used in several studies
of COPD patients, including in Norway [22,23]. The
questionnaire has been tested for reliability and validity in
different studies and the results showed satisfactory relia-
bility and validity in COPD patients [24-26]. Only the
symptom component, which measures breathlessness in
terms of frequency and distress [18], was used in this
study. The symptom component consists of 8 items
including frequencies and distress of breathlessness in
term of phlegm/sputum, shortness of breath, wheezing
and chest trouble [18,21].
Anxiety and depression
Anxiety and depression were measured with the Hospital
Anxiety and Depression Scale (HADS). HADS is a ques-
tionnaire developed to measure anxiety and depression in
non-psychiatric patients treated at hospital clinics. The
questionnaire consists of 14 items. Seven items measure
anxiety (HADS-A) and seven items measure depression
(HADS-D). The items are scored on a four-step scale rang-Page 3 of 8
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one depression scale are scored by summing the patient's
responses. The scores range from 0–21, with higher scores
indicating higher anxiety and depression [27,28]. HADS
has been thoroughly tested for psychometric properties
[27-30] and has been used in patients suffering from
COPD and the general population in Norway [31-33].
(D) Physical function
Data on physical function were collected during the exam-
ination at the out-patient clinic.
Exercise capacity
Exercise capacity was measured with the ISWT. The ISWT
is a standardized progressive walking test used to measure
functional exercise capacity in patients with cardiorespira-
tory conditions. The test requires patients to walk at
increasing speeds up and down a 10-metre course. The
speed of walking increases every minute and is controlled
by audio signals played on a DVD. The distance walked is
reported in metres and greater distances indicate better
exercise capacity [34]. The ISWT has shown satisfactory
reliability and validity in COPD patients [34,35].
(E) Subjective health status
Physical and mental health
The Short Form 36 health survey (SF-36) was used to
measure physical and mental health. SF-36 is one of sev-
eral generic questionnaires developed in the United States
by the Medical Outcomes Study to assess subjective health
status [36]. The questionnaire consists of 36 questions
that measure eight conceptual components: physical
functioning, physical role limitations, bodily pain, self-
reported general health, vitality, social function, emo-
tional role limitations, and mental health. The scores in
each component and the total scores are transformed
onto 0–100 scales. Higher scores indicate better subjective
health status [36]. One physical health summary score
and one mental health summary score were computed
from the eight dimension scores. The physical health
summary score is mainly based on the physical health,
physical role limitations, bodily pain, and general health
components, whereas the mental health summary score is
mainly based on the vitality, social function, emotional
role limitations, and mental health components [37]. In
this study, we used the physical and mental health sum-
mary scores. The questionnaire has shown satisfactory
reliability and validity in COPD patients, and has been
thoroughly tested for psychometric properties in several
countries, including Norway [38-41].
Statistical analysis
The data were analysed with SPSS for Windows version
15.0 (SPSS Inc., Chicago, IL, USA). Missing data for the
SF-36 and SGRQ were accommodated according to the
user manuals [21,36]. For the HADS, missing data were
accommodated for individuals who had responded to five
or more of the seven items of HADS-A or HADS-D [30].
Descriptive analyses (mean, standard deviation [SD],
range) were used. Simple and multiple linear regression
analyses were used to investigate the relationships
between demographics, physiological variables, symp-
toms, physical function, and subjective health status. In
the multiple linear regressions, the analysis demographics
were entered as independent variables. Physiological var-
iables, symptoms, and physical function values were used
as both independent and dependent variables, and sub-
jective health status was entered as a dependent variable
according to the model shown in Figure 1. In the present
study, p < 0.05 was considered statistically significant.
Results
Descriptive
The sample consisted of 100 (response rate, 74%) patients
suffering from COPD and awaiting participation in an
outpatient pulmonary rehabilitation programme. The
characteristics of the responders are shown in Table 1.
Relationships between age, sex, physiological variables, 
and symptoms
In the bivariate analysis, age (regression coefficient = -
0.75, p = 0.025) and predicted FEV1% (regression coeffi-
cient = -0.42, p = 0.024) showed a significant relationship
to breathlessness, and sex (difference = -1.86, p = 0.017)
to anxiety (level 0, Additional file 1). When both demo-
graphic and physiological variables were entered in the
analysis, age (regression coefficient = -0.84, p = 0.019)
and sex (difference = -2.21, p = 0.011) still showed a sig-
nificant relationship to breathlessness and anxiety (level
2, Additional file 1).
Relationships between age, sex, physiological variables, 
symptoms, and physical function
Age (regression coefficient = -7.12, p = 0.001), predicted
FEV1% (regression coefficient = 2.97, p = 0.015), anxiety
(regression coefficient = -9.22, p = 0.041), and depression
(regression coefficient = -16.26, p < 0.001) showed signif-
icant bivariate relationships to exercise capacity (level 0,
Additional file 1). When all the variables were entered
into the regression analysis, age (regression coefficient = -
7.45, p < 0.001), sex (difference = 76.41, p = 0.022), pre-
dicted FEV1% (regression coefficient = 2.71, p = 0.020),
and depression (regression coefficient = -14.22, p = 0.009)
showed significant relationships to exercise capacity (level
3, Additional file 1).
Relationships between age, sex, physiological variables, 
symptoms, physical function, and subjective health status
In the bivariate analysis, predicted FEV1% (regression
coefficient = 0.19, p = 0.007), breathlessness (regressionPage 4 of 8
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cient = -1.04, p < 0.001), depression (regression coeffi-
cient = -1.54, p < 0.001), and exercise capacity (regression
coefficient = 0.02, p = 0.021) were significantly associated
with physical health (level 0, Additional file 1). When
demographics, physiological variables, symptoms, and
physical function were entered into the analysis, only
breathlessness (regression coefficient = -0.09, p = 0.027)
and depression (regression coefficient = -0.88, p = 0.015)
were significantly associated with physical health (level 4,
Additional file 1).
Our results also showed significant bivariate relationships
between anxiety (regression coefficient = -1.74, p <
0.001), depression (regression coefficient = -1.80, p <
0.001), exercise capacity (regression coefficient = 0.02, p =
0.031), and mental health (level 0, Additional file 1).
When all the variables were entered into the regression
analysis, predicted FEV1% (regression coefficient = -0.14,
p = 0.043), anxiety (regression coefficient = -0.85, p =
0.004), and depression (regression coefficient = -1.31, p <
0.001) showed significant relationships to mental health
(level 4, Additional file 1).
Age and sex account for only -1% and 1%, respectively, of
the adjusted R2 for physical and mental health. When the
physiological variables were entered into the model, the
adjusted R2 increased to 1% for physical health and 2%
for mental health. When symptoms were added, the
explained variance increased to 36% for physical health
and 53% for mental health, whereas physical function
added no substantial variance. When all the variables
were entered into the regression analysis, the explained
variance was 37% for the physical health component and
53% for the mental health component (levels 1–4, Addi-
tional file 1).
Internal consistence
In this study, Cronbach's alpha was 0.86, 0.85, and 0.87 for
the symptom, activity, and impact components, respectively,
and 0.93 for the total score of the SGRQ. With regard to
HADS, Cronbach's alpha was 0.85 for anxiety and 0.84 for
depression. Cronbach's alpha ranged from 0.77 to 0.90 for
SF-36 subscales. The lowest value was observed for the gen-
eral health component (0.77) and the highest value for the
bodily pain component (0.90).
Discussion
The results of this study show that patients with more
breathlessness and depression reported lower physical
health. Moreover, those with better lung function but
more anxiety and depression reported lower mental
health. These results also show that symptoms explain a
greater proportion of the variance in subjective health sta-
tus than do demographics, physiological variables, or
physical function. According to the biopsychosocial
model, no one single factor explains the subjective health
status. Instead, it reflects the complexity of the associa-
tions between biological and psychosocial factors,
progresses of symptoms, to clusters of symptoms, to syn-
dromes, and finally to diseases with specific pathogeneses
and pathology [14].
Table 1: Characteristics of the responders (N = 100)
N (%) Mean (SD) Range





FEV1 (litre)a 1.31 (0.50) 0.42–2.54
FEV1% predicteda 46.0 (15.0) 16–79
FEV1/FVC%a 51.6 (12.5) 28–69
Transcutaneus oxygen saturation (SaO2%)a 96.0 (1.9) 88–99
Breathlessness (SGRQ)b
(0–100) 49.8 (27.8) 0.0–97.5
Anxiety (HADS-A)b
(0–21) 5.9 (3.9) 0.0–17.0
Depression (HADS-D)b
(0–21) 4.5 (3.7) 0.0–19.0
Exercise capacity (ISWT)a
(metre) 336.7 (163.9) 57.0–770.0
Physical health summary scale (SF-36)a 38.4 (9.9) 14.7–58.2
Mental health summary scale(SF-36)a 48.6 (10.4) 20.8–68.3
aHigher score indicate better lung function, oxygen saturation, exercise capacity and physical and mental health.bHigher score indicate more 
breathlessness, anxiety and depression.Page 5 of 8
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on subjective health status in COPD patients based on
Wilson and Cleary's [4] conceptual model of biopsycho-
social relationships to subjective health status. In this
study, a conceptual model was established based on Wil-
son and Cleary's framework and previous COPD-specific
studies. In the model, there is a unidirectional relation-
ship between the biological and physiological variables,
symptoms, and physical function, which leads to the sub-
jective health status (Figure 1). According to Osoba [42],
there is a reasonably strong correlation between the prox-
imal components of Wilson and Cleary's model (such as
symptoms and physical function) and a weaker correla-
tion between the more distant components (such as the
physiological variables and subjective health status).
There may also be a bidirectional relationship between
some components [42]. There is not necessarily a strong
association between the objective physiological indicators
of the disease and the patients' subjective experience of
their health status. In this respect, studies of COPD
patients have found weak associations between objective
measures of disease, symptoms, physical function, and
subjective health status [11,13,22,43].
Relationships between age, sex, and physiological 
variables
The results of this study show insignificant associations
between age, sex, and oxygen saturation. Conflicting results
have been found in previous studies. De Torres et al. [5]
found that women suffering from COPD tended to have bet-
ter oxygen saturation than men. Conversely, Di Marco et al.
[43] found an insignificant association between sex and oxy-
gen saturation. Insignificant associations between age, sex,
and oxygen saturation suggest that the women and men
studied were at the same stage of COPD [5,44].
Relationships between age, sex, physiological variables, 
and symptoms
The observation that older COPD patients report less
breathlessness than younger is in contrast to Stavem et al
[45] who not find any such association. This finding may
be due to response shift [46]. Patients adapt over time in
relation to goals, expectations and values, and their per-
ceptions of symptoms may therefore change. Further-
more, the process of learning to cope with health
problems is well-known in chronically ill patients [46].
Older COPD patients may have suffered longer from
COPD and anticipate illness as part of growing old. More-
over, health- related stressors may not produce the same
reactions in elderly. Although older patients may have dif-
ficulties due to breathlessness, they may see physical and
functional disability as result in growing older [8,47]. The
fact that women tend to report more anxiety than men is
not surprising because there is ample evidence of a higher
prevalence of anxiety among woman than among men
[48,49]. That women report more anxiety than men is also
consistent with previous studies of COPD patients
[13,43]. In this study, small and insignificant associations
were identified between physiological variables and
symptoms. These results are in accordance with previous
studies of COPD patients, which found small and insig-
nificant associations between physiological measure-
ments and breathlessness, anxiety, and
depression[7,11,22,43,45].
Relationships between age, sex, physiological variables, 
symptoms, physical function, and subjective health status
Patients with less breathlessness and depression reported
better physical health, and those with less anxiety and
depression reported better mental health, which is con-
sistent with previous studies of COPD patients [8,45,50].
However, it is surprising that lung function was not asso-
ciated with physical health and that better lung function
was associated with worse mental health. The same trend
was observed in other studies of COPD patients, although
the association was not statistically significant [45,51].
The results of our study show that the association between
symptoms and subjective health status was stronger than
the association between physiological variables and sub-
jective health status, and this supports the multidimen-
sional impact of COPD on subjective health status [42].
Furthermore, the fact that subjective health status repre-
sents something other than physiological and pathologi-
cal factors is useful information for consideration in the
treatment and care of COPD patients [7,45,52].
Limitations
In this study, age, sex, lung function, oxygen saturation,
breathlessness, anxiety, depression, and exercise capacity
influenced subjective health status. However, according to
previous studies of COPD patients, body mass index, edu-
cation, social status, sleeping habits, and co-morbidity
could be important supplementary factors affecting sub-
jective health status in this sample [10,12,13]. This study
is limited to some degree. The sample size was quite
small, which restricts the number of factors included in
the multivariate testing of subjective health status [53].
Because of the cross-sectional design, no absolute conclu-
sions can be drawn about causality or the directions of the
relationships between many of the variables [54]. The
patients included in this study were awaiting participation
in a pulmonary rehabilitation programme, and were thus
not a representative sample of all COPD patients. The
strength of this study is its multivariate approach to
explaining subjective health status. According to the
biopsychosocial model, subjective health status is associ-
ated with physiological factors as well as symptoms and
psychosocial factors [14].
Implications for clinical practice
The results of this study indicate that symptoms are very
important to patients' subjective health status, which inPage 6 of 8
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programme focusing on the management of symptoms,
such as breathlessness, anxiety, and depression, is
required to alleviate symptoms and increase subjective
health status[55].
A model that explains the relationships between different
outcomes is important in clinical practice to correctly
interpret the results of outcome assessments [4,42]. For
example, if subjective health status is determined by
symptoms and physical function, then symptoms and
physical function should be treated [42]. In COPD, symp-
toms such as breathlessness, anxiety, and depression are
usually evident before there is a reduction in subjective
health status. However, it is more difficult to determine
the causal direction between breathlessness, anxiety,
depression, and physical function, and as breathlessness,
anxiety, and depression may be caused by a decrease in
function [52,56].
Conclusion
When controlled for all variables, more breathlessness
and depression were associated with lower physical
health, and better lung function, and greater anxiety and
depression were associated with a lower mental health,
with symptoms explaining the greatest variance. These
findings highlight the importance of rehabilitation pro-
grammes that focus on the management of symptoms in
relation to COPD.
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